SCHEMBL2805767

SCHEMBL2805767

O=C(NS(=O)(=O)C1CC1)c1cnn2c(NCc3ccccc3)c(C(=O)N3CCC(c4ccccc4)CC3)cnc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RBP4 P02753 1/20 0.37
THRB P10828 1/20 0.37
STAT6 P42226 1/20 0.37
ENPP2 Q13822 1/20 0.37
SPR P35270 3/20 0.37
EGLN1 Q9GZT9 3/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
SIRT5 Q9NXA8 1/20 0.35
ALDH1A1 P00352 3/20 0.35
LMNA P02545 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
TP53BP1 Q12888 1/20 0.35
L3MBTL3 Q96JM7 1/20 0.35
TSHR P16473 1/20 0.34
HKDC1 Q2TB90 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2799687 0.92 STAT6 (0.40) RBP4THRBSTAT6ENPP2SPR
SCHEMBL2802824 0.90 STAT6 (0.39) THRBSTAT6ENPP2SPRCA12
SCHEMBL2799699 0.90 SPR (0.38) THRBSTAT6ENPP2SPREGLN1
SCHEMBL2804072 0.90 STAT6 (0.41) THRBSTAT6ENPP2SPRCA12
SCHEMBL2801068 0.90 RBP4 (0.39) RBP4THRBSTAT6ENPP2SPR
SCHEMBL2803145 0.90 STAT6 (0.38) THRBSTAT6ENPP2SPRCA12
SCHEMBL2800008 0.89 TPSAB1 (0.38) THRBSTAT6ENPP2SPREGLN1
SCHEMBL2801524 0.88 ALDH1A1 (0.37) THRBSTAT6ENPP2ALDH1A1TSHR
SCHEMBL2800936 0.88 STAT6 (0.42) THRBSTAT6ENPP2SPRSIRT5
SCHEMBL2802391 0.87 SMN1; SMN2 (0.41) THRBSTAT6ENPP2SPREGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2206714-B1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO LTD (JP) 2015-01-21 EP disclosed
US-8729264-B2 Agent for prevention and/or treatment of skin diseases KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-05-20 US disclosed
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-10-07 US disclosed
EP-2206714-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES Kyowa Hakko Kirin Co., Ltd. (JP) 2010-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES TYR, CUTA, SERPINB1 RBP4 92/4885THRB 4546/4885STAT6 146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.